Drug intelligence / Profile preview

68Ga-NOTA-PTDGd

Development stage
Unknown
Lead developer
Peking University Health Science Center
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Peptides
Administration
Intravenous
01

Overview

68Ga-NOTA-PTDGd is a radiolabeled peptide-based PET imaging agent developed for the non-invasive assessment of galectin-1 (Gal-1) expression, which serves as a surrogate marker for tumor hypoxia. The tracer consists of the PTDGd peptide, which exhibits high affinity for Gal-1, conjugated to the chelator NOTA and labeled with the positron-emitting isotope Gallium-68. Galectin-1 is a carbohydrate-binding protein that is significantly upregulated in the hypoxic regions of various solid tumors and plays a critical role in tumor angiogenesis, immunosuppression, and metastasis. By targeting Gal-1, 68Ga-NOTA-PTDGd allows for the visualization and quantification of hypoxic tumor microenvironments, potentially aiding in tumor staging, treatment planning, and monitoring response to therapies that target hypoxia or Gal-1. The development is primarily associated with researchers at Peking University.

Other names
[68Ga]Ga-NOTA-PTDGdGa-68 NOTA-PTDGdGa68 NOTA-PTDGdGa 68 NOTA-PTDGd
02

Targets

LGALS1 (Galectin-1)

Beyond the preview

Go deeper on 68Ga-NOTA-PTDGd.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 68Ga-NOTA-PTDGd.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call